2822 related articles for article (PubMed ID: 7989119)
1. Identification and characterization of autocrine-motility-factor-like activity in oral squamous-cell-carcinoma cells.
Ishisaki A; Oida S; Momose F; Amagasa T; Rikimaru K; Ichijo H; Sasaki S
Int J Cancer; 1994 Dec; 59(6):783-8. PubMed ID: 7989119
[TBL] [Abstract][Full Text] [Related]
2. Regulation of melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE.
Timar J; Silletti S; Bazaz R; Raz A; Honn KV
Int J Cancer; 1993 Dec; 55(6):1003-10. PubMed ID: 8253518
[TBL] [Abstract][Full Text] [Related]
3. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of the motility responses in malignant tumor cells: a biological basis for the diversity and homing of metastatic cells.
Kohn EC; Francis EA; Liotta LA; Schiffmann E
Int J Cancer; 1990 Aug; 46(2):287-92. PubMed ID: 2116998
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
Watanabe H; Takehana K; Date M; Shinozaki T; Raz A
Cancer Res; 1996 Jul; 56(13):2960-3. PubMed ID: 8674049
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cell motility via high and low affinity autocrine motility factor (AMF) receptor in human oral squamous carcinoma cells.
Niinaka Y; Haga A; Negishi A; Yoshimasu H; Raz A; Amagasa T
Oral Oncol; 2002 Jan; 38(1):49-55. PubMed ID: 11755821
[TBL] [Abstract][Full Text] [Related]
7. Autocrine motility factor is a growth factor.
Silletti S; Raz A
Biochem Biophys Res Commun; 1993 Jul; 194(1):446-57. PubMed ID: 8392842
[TBL] [Abstract][Full Text] [Related]
8. Comparison of autocrine mechanisms promoting motility in two metastatic cell lines: human melanoma and ras-transfected NIH3T3 cells.
Seiki M; Sato H; Liotta LA; Schiffmann E
Int J Cancer; 1991 Nov; 49(5):717-20. PubMed ID: 1657797
[TBL] [Abstract][Full Text] [Related]
9. Tumor autocrine motility factor is an angiogenic factor hat stimulates endothelial cell motility.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2001 Jun; 284(5):1116-25. PubMed ID: 11414699
[TBL] [Abstract][Full Text] [Related]
10. Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy.
Yanagawa T; Funasaka T; Tsutsumi S; Watanabe H; Raz A
Endocr Relat Cancer; 2004 Dec; 11(4):749-59. PubMed ID: 15613449
[TBL] [Abstract][Full Text] [Related]
11. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
[TBL] [Abstract][Full Text] [Related]
12. Induction of autocrine factor inhibiting cell motility from murine B16-BL6 melanoma cells by alpha-melanocyte stimulating hormone.
Murata J; Ayukawa K; Ogasawara M; Watanabe H; Saiki I
Int J Cancer; 1999 Mar; 80(6):889-95. PubMed ID: 10074923
[TBL] [Abstract][Full Text] [Related]
13. Autocrine motility factor stimulates a three-fold increase in inositol trisphosphate in human melanoma cells.
Kohn EC; Liotta LA; Schiffmann E
Biochem Biophys Res Commun; 1990 Jan; 166(2):757-64. PubMed ID: 2154219
[TBL] [Abstract][Full Text] [Related]
14. Differential purification of autocrine motility factor derived from a murine protein-free fibrosarcoma.
Watanabe H; Kanbe K; Chigira M
Clin Exp Metastasis; 1994 Mar; 12(2):155-63. PubMed ID: 8306529
[TBL] [Abstract][Full Text] [Related]
15. Identification of B16-F1 melanoma autocrine motility-like factor receptor.
Nabi IR; Watanabe H; Raz A
Cancer Res; 1990 Jan; 50(2):409-14. PubMed ID: 2153051
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell autocrine motility factor receptor.
Nabi IR; Watanabe H; Silletti S; Raz A
EXS; 1991; 59():163-77. PubMed ID: 1655517
[TBL] [Abstract][Full Text] [Related]
18. Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2001 Jul; 285(1):118-28. PubMed ID: 11437381
[TBL] [Abstract][Full Text] [Related]
19. Purification of B16-F1 melanoma autocrine motility factor and its receptor.
Silletti S; Watanabe H; Hogan V; Nabi IR; Raz A
Cancer Res; 1991 Jul; 51(13):3507-11. PubMed ID: 1647268
[TBL] [Abstract][Full Text] [Related]
20. Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.
Silletti S; Paku S; Raz A
Am J Pathol; 1996 May; 148(5):1649-60. PubMed ID: 8623932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
